Bioavailability Enhancement Bioconjugates/ADC Drug Substance/HPAPI Early De-Risking & Optimization First-in-Human Ibex® Dedicate IND-to-BLA Inhalation Mammalian Expression Systems Microbial Expression Systems Molecular Biology mRNA/LNP Multiparticulates Out-Licensed Expression Technologies Parenteral Drug Product PBPK Modeling Process Development & Optimization Protein Expression Small Molecules - Commercial Solid Form Selection
Biologics (35) Small Molecules (30)
Abhijeet Sinha, Ph.D.
Abhijeet Sinha, Ph.D.
Solid Form Selection
Explore expertise
Alice Harrison
Alice Harrison
Mammalian Expression Systems
Explore expertise
Andreas Sieber, Ph.D.
Andreas Sieber, Ph.D.
Solid Form Selection
Explore expertise
Andrew Brown
Andrew Brown
Mammalian Expression Systems
Explore expertise
Antoine Klaue
Antoine Klaue
Drug Substance/HPAPI
Explore expertise
Arundhati Chattopadhyay, Ph.D.
Arundhati Chattopadhyay, Ph.D.
Parenteral Drug Product
Explore expertise
Beatriz Fernandes
Beatriz Fernandes
Inhalation
Explore expertise
Bernhard Gutmann, Ph.D.
Bernhard Gutmann, Ph.D.
Drug Substance/HPAPI
Explore expertise
Bernhard Stump, Ph.D.
Bernhard Stump, Ph.D.
Bioconjugates/ADC | IND-to-BLA
Explore expertise
Bernie Sweeney
Bernie Sweeney
Mammalian Expression Systems | Out-Licensed Expression Technologies
Explore expertise
Brian Schwegler
Brian Schwegler
Drug Substance/HPAPI
Explore expertise
Cameron Kadleck
Cameron Kadleck
Inhalation
Explore expertise
Carmen Juds, Ph.D.
Carmen Juds, Ph.D.
Bioconjugates/ADC
Explore expertise
Charles Johnson
Charles Johnson
Drug Substance/HPAPI
Explore expertise
Christian Noti, Ph.D.
Christian Noti, Ph.D.
Drug Substance/HPAPI
Explore expertise
Christoph Grapentin, Ph.D.
Christoph Grapentin, Ph.D.
Parenteral Drug Product
Explore expertise
Claudia Müller, Ph.D.
Claudia Müller, Ph.D.
Parenteral Drug Product
Explore expertise
Clemens Jakobi
Clemens Jakobi
mRNA/LNP
Explore expertise
Cody Prather
Cody Prather
Inhalation
Explore expertise
Conrad Roten, Ph.D.
Conrad Roten, Ph.D.
Drug Substance/HPAPI
Explore expertise
David Hall
David Hall
Small Molecules - Commercial
Explore expertise
David Lyon, Ph.D.
David Lyon, Ph.D.
Bioavailability Enhancement
Explore expertise
Dominique Roberge, Ph.D.
Dominique Roberge, Ph.D.
Drug Substance/HPAPI
Explore expertise
Elisabeth Engelsberger, Ph.D.
Elisabeth Engelsberger, Ph.D.
Bioconjugates/ADC
Explore expertise
Federico Sabini
Federico Sabini
Parenteral Drug Product
Explore expertise
Fred Bathke
Fred Bathke
Parenteral Drug Product
Explore expertise
Friederike Hermann, Ph.D.
Friederike Hermann, Ph.D.
Drug Substance/HPAPI
Explore expertise
Giovanna Libralon
Giovanna Libralon
Small Molecules - Commercial
Explore expertise
Gordon Bates
Gordon Bates
Small Molecules - Commercial
Explore expertise
Hannah Sullivan, PE
Hannah Sullivan, PE
Multiparticulates
Explore expertise
Heiko Nalenz, Ph.D.
Heiko Nalenz, Ph.D.
Parenteral Drug Product
Explore expertise
Iwan Bertholjotti
Iwan Bertholjotti
Bioconjugates/ADC | Ibex® Dedicate
Explore expertise
Jean-Sebastien Steffen, Ph.D.
Jean-Sebastien Steffen, Ph.D.
Parenteral Drug Product
Explore expertise
Jimmy Rosedale
Jimmy Rosedale
Inhalation
Explore expertise
Jin Lu, Ph.D.
Jin Lu, Ph.D.
Mammalian Expression Systems | Out-Licensed Expression Technologies
Explore expertise
Joachim Klein, Ph.D.
Joachim Klein, Ph.D.
Microbial Expression Systems | Out-Licensed Expression Technologies
Explore expertise
Joachim Schuster, Ph.D.
Joachim Schuster, Ph.D.
Parenteral Drug Product
Explore expertise
Joel Wood
Joel Wood
Bioavailability Enhancement
Explore expertise
Josh Marsh
Josh Marsh
PBPK Modeling
Explore expertise
Kee Cheung
Kee Cheung
Mammalian Expression Systems | Out-Licensed Expression Technologies
Explore expertise
Kimberly Shepard, Ph.D.
Kimberly Shepard, Ph.D.
Inhalation
Explore expertise
Léa Sorret, Ph.D.
Léa Sorret, Ph.D.
Parenteral Drug Product
Explore expertise
Lisa Prendergast, Ph.D.
Lisa Prendergast, Ph.D.
Molecular Biology
Explore expertise
Logan Howell
Logan Howell
Multiparticulates
Explore expertise
Mark Cappucci
Mark Cappucci
First-in-Human
Explore expertise
Matthew Ferguson
Matthew Ferguson
Inhalation
Explore expertise
Maureen Kadleck
Maureen Kadleck
Inhalation
Explore expertise
Maurits Janssen, Ph.D.
Maurits Janssen, Ph.D.
Drug Substance/HPAPI
Explore expertise
Maurizio Muroni, Ph.D.
Maurizio Muroni, Ph.D.
Mammalian Expression Systems | Process Development & Optimization
Explore expertise
Molly Adam
Molly Adam
Bioavailability Enhancement
Explore expertise
Monika Geiger, Ph.D.
Monika Geiger, Ph.D.
Parenteral Drug Product
Explore expertise
Neil Taylor
Neil Taylor
Early De-Risking & Optimization | Molecular Biology
Explore expertise
Niklaus Künzle, Ph.D.
Niklaus Künzle, Ph.D.
Drug Substance/HPAPI
Explore expertise
Nikolay Krumov, Ph.D.
Nikolay Krumov, Ph.D.
Microbial Expression Systems | Out-Licensed Expression Technologies
Explore expertise
Noel Smith, Ph.D.
Noel Smith, Ph.D.
Early De-Risking & Optimization
Explore expertise
Orla McGarvey, Ph. D.
Orla McGarvey, Ph. D.
Parenteral Drug Product
Explore expertise
Peter O'Callaghan, Ph.D.
Peter O'Callaghan, Ph.D.
Mammalian Expression Systems | Out-Licensed Expression Technologies
Explore expertise
Qifeng Zhang
Qifeng Zhang
Mammalian Expression Systems
Explore expertise
Raphael Frey, Ph.D.
Raphael Frey, Ph.D.
Bioconjugates/ADC | Early De-Risking & Optimization
Explore expertise
Raymond Donninger, MD, MBA
Raymond Donninger, MD, MBA
Early De-Risking & Optimization
Explore expertise
Rebecca Michael, Ph.D.
Rebecca Michael, Ph.D.
Molecular Biology
Explore expertise
Salvatore Mercuri, Ph.D.
Salvatore Mercuri, Ph.D.
Bioavailability Enhancement
Explore expertise
Sandro Holzer
Sandro Holzer
Bioconjugates/ADC
Explore expertise
Sanghee Yang
Sanghee Yang
Parenteral Drug Product
Explore expertise
Stuart Jamieson
Stuart Jamieson
Mammalian Expression Systems
Explore expertise
Vinay Kamuju
Vinay Kamuju
Parenteral Drug Product
Explore expertise
Yvette Stallwood, Ph.D.
Yvette Stallwood, Ph.D.
Early De-Risking & Optimization
Explore expertise